BBIO · BridgeBio Pharma, Inc. · Documents
$65.80
-0.17 (-0.26%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$12.90B
Shares
195.49M
Volume · Sep 30
2.82M
Avg daily vol (3M)
2.75M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-09-09 | 2026-09-30 | |
| 8-K | 2026-08-31 | — | |
| 8-K | 2026-08-17 | 2026-08-13 | |
| 10-Q | 2026-08-10 | 2026-06-30 | |
| 8-K | 2026-08-10 | — | |
| 8-K | 2026-07-22 | — | |
| 8-K | 2026-07-02 | 2026-07-01 | |
| 8-K | 2026-06-26 | 2026-06-22 | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-05-27 | — | |
| 8-K | 2026-05-13 | 2026-05-12 | |
| 8-K | 2026-05-08 | 2026-05-07 | |
| 8-K | 2026-05-07 | 2026-05-06 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-24 | 2026-06-22 | |
| 8-K | 2026-03-30 | — | |
| Investor Event Transcript | 2026-03-10 | 2026-03-31 | |
| Investor Event Transcript | 2026-03-02 | 2026-03-31 | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-01-21 | 2026-01-14 | |
| 8-K | 2026-01-12 | — | |
| Investor Event Transcript | 2025-12-03 | 2025-12-31 | |
| Investor Event Transcript | 2025-11-18 | 2025-12-31 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-10-29 | — | |
| 10-Q | 2025-10-29 | 2025-09-30 | |
| 8-K | 2025-10-27 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-07-02 | 2025-06-27 | |
| 8-K | 2025-06-23 | 2025-06-20 | |
| DEF 14A | 2025-04-30 | 2025-06-20 | |
| 10-Q | 2025-04-29 | 2025-03-31 | |
| 8-K | 2025-04-29 | — | |
| 8-K | 2025-03-17 | — | |
| 8-K | 2025-02-28 | 2025-02-24 | |
| 10-K | 2025-02-20 | 2024-12-31 | |
| 8-K | 2025-02-20 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-25 | 2024-11-22 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-09-11 | 2024-09-10 | |
| 8-K | 2024-08-21 | 2024-08-16 | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-07-23 | — |
Showing 1–50 of 141 filings
Key facts
CIK
1743881
CUSIP
10806X102
13F (30d)
13 filings
12 filers
Visit website
Investor relations